Paper Details

  1. Home
  2. Paper Details

Switch to rilpivirine improves diabetes in an elderly HIV-positive patient.

Author: Di RosaZaira, FalascaKatia, UcciferriClaudio, VecchietJacopo, VignaleFrancesca

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This case report highlights the development of unbalanced diabetes in a 72-year-old man with long-term HIV infection treated with zidovudine. Switching to rilpivirine significantly improved diabetes control, suggesting that rilpivirine might be a better option for patients with HIV infection who experience glucose metabolism issues associated with zidovudine.
Paper Details　
Original Abstract of the Article :
Glucose intolerance and diabetes are becoming increasingly common in HIV-infected patients in the cART era. Many factors are associated with the development of diabetes in HIV-infected individuals who receive cART, one of which is the assumption of specific antiretroviral classes or agents. We descr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/30882388

データ提供：米国国立医学図書館（NLM）

Rilpivirine: A Beacon of Hope in the Desert of HIV

HIV infection, a challenging condition in the desert of infectious diseases, requires careful management and treatment. This case report, like a story of resilience in a harsh landscape, explores the impact of switching from zidovudine to rilpivirine on glucose metabolism in an elderly HIV-positive patient. The patient, experiencing unbalanced diabetes, found significant improvement in glucose control after the switch. This case suggests that rilpivirine may be a valuable alternative for patients with HIV who are experiencing glucose intolerance or diabetes, potentially offering a better quality of life.

A New Oasis in the Desert of HIV

This case study, like a refreshing oasis in the desert of HIV, provides a compelling example of how switching medications can improve patient outcomes. The patient's experience highlights the importance of individualizing treatment strategies and considering the potential impact of antiretroviral medications on glucose metabolism.

Navigating the Desert of HIV Treatment

For patients with HIV, this case underscores the importance of ongoing monitoring and open communication with healthcare providers. It's crucial to discuss potential side effects and discuss alternative treatment options as needed. Remember, navigating the desert of HIV treatment requires a collaborative approach, involving patients, healthcare providers, and researchers.

Dr. Camel's Conclusion

This case report, like a lone camel navigating a challenging desert, underscores the importance of individualizing HIV treatment strategies. The patient's experience highlights the potential of rilpivirine to improve glucose control and enhance quality of life for patients with HIV.

Date :
  1. Date Completed 2019-11-22
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

30882388

DOI: Digital Object Identifier

30882388

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.